Risk stratification and dental management of the patient with cardiovascular diseases. Part II: Oral disease burden and principles of dental management

Quintessence International

Volumn 36, Issue 3, 2005, Pages 209-227

  Steinhauer, Tad ^a   Bsoul, Samer A ^b   Terezhalmy, Geza T ^b  

^a University Schools   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cardiac arrhythmia; Coronary artery disease; Dental management; Heart failure; Hypertension; Oral disease; Thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CEVIMELINE; CHLORHEXIDINE GLUCONATE; CLOPIDOGREL; FLUORIDE; FLUORIDE SODIUM; HEMOSTATIC AGENT; HEPARIN; PILOCARPINE; WARFARIN;

BLEEDING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERY DISEASE; DENTAL ANESTHESIA; DENTAL CARE; DENTAL CARIES; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SAFETY; GINGIVA HYPERPLASIA; GINGIVITIS; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; LICHENOID ERUPTION; LOCAL ANESTHESIA; MOUTH DISEASE; MOUTH HYGIENE; OUTCOMES RESEARCH; PATIENT COUNSELING; PERIODONTAL DISEASE; PHYSICAL EXAMINATION; PRESCRIPTION; PREVENTIVE DENTISTRY; REVIEW; RISK ASSESSMENT; STOMATITIS; STRATIFICATION; THROMBOEMBOLISM; TOPICAL TREATMENT; TREATMENT INDICATION; UNITED STATES; XEROSTOMIA;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DENTAL CARE FOR CHRONICALLY ILL; DENTAL CARIES; GINGIVAL HYPERPLASIA; GINGIVITIS; HUMANS; LICHEN PLANUS; PACEMAKER, ARTIFICIAL; PERIODONTAL DISEASES; RISK ASSESSMENT; XEROSTOMIA;

EID: 13944269108     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Beck JD, Pankow J, Tyroler HA, Offenbacker S. Dental infections and atherosclerosis. Am Heart J 1999;138:S528-S533.
2. Valtonen VV. Role of infection in atherosclerosis. Am Heart J 1999;138:S431-S433.
3. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. Br Med J 1989;298:779-781.
4. Genco RJ. Periodontal disease and risk for myocardial infarction and cardiovascular disease. Cardiovasc Rev Rep 1998;19:34-40.
5. Nery EB, Meister F, Ellinger RF, Eslami A, McNamara TJ. Prevalence of medical problems in periodontal patients obtained from three different populations. J Clin Periodontol 1987;58:564-568.
6. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. Br Med J 1993;306:688-691.
7. Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi DL. Dental infections and coronary atherosclerosis. Atherosclerosis 1993;103:205-211.
8. Umino M, Nagao M. Systemic diseases in elderly dental patients. Int Dent J 1993;43:213-218.
9. Mattila KJ, Valtonen VV, Nieminen M, Huttunen JK. Dental infection and the risk of new coronary events: Prospective study of patients with documented coronary artery disease. Clin Infect Dis 1995;20:588-592.
10. Joshipura KJ, Rimm EB, Douglass CW, Trichopoulos D, Ascherio A, Willet WC. Poor oral health and coronary heart disease. J Dent Res 1996;75:1631-1636.
11. Beck JD, Garcia RI, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123-1137.
12. Grau AJ, Buggle F, Ziegler C, et al. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke 1997;28:1724-1729.
13. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. Periodontitis: A risk factor for coronary heart disease. Ann Periodontol 1998;3:127-141.
14. Syrjanen J, Peltola J, Valtonen V, Iivannnainen M, Kaste M, Huttunen JK. Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med 1989;25:179-184.
15. Dorn BR, Dunn WA Jr, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immunol 1999;67:5792-5798.
16. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and coronary heart disease risk. J Am Med Assoc 2000;284:1406-1410.
17. Scannapieco FA. Position paper of the American Academy of Periodontology: Periodontal disease as a potential risk factor for systemic disease. J Periodontol 1998;69:841-850.
18. Hay KD, Reade PC. Methyldopa as a cause of oral mucous membrane reactions. Br J Dent 1978;145:195-203.
19. Williams BG. Oral drug reaction to methyldopa. Report of a case. Oral Surg Oral Med Oral Pathol 1983;56:375-377.
20. Brooks SL. Lichenoid reaction of oral mucosa and skin to methyldopa. J Oral Med 1982;37:42-44.
21. Firth NA, Reade PC. Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions. Oral Surg Oral Med Oral Pathol 1989;67:41-44.
22. Robertson WR, Wray D. Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol 1992;74:183-185.
23. Hay KD, Reade PC. Spectrum of oral disease induced by drugs and other bioactive agents. Drugs 1983;26:268-277.
24. Eversole LE. Allergic stomatitides. J Oral Med 1979;34:93-102.
25. Reed WD, Becker SW. Lichenoid drug eruptions from gold, chroroquine, and chlorothiazide. GP 1962;25:118-123.
26. Van Dis ML, Parks ET. Prevalence of oral lichen planus in patients with diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:696-700.
27. Glass BJ, Van Dis ML, Langlais RP, Miles DA. Xerostomia: Diagnosis and treatment planning considerations. Oral Surg Oral Med Oral Pathol 1984;58:248-252.
28. Zelickson BD, Rogers RS III. Oral drug reactions. Dermatol Clin 1987;5:695-708.
29. Schubert MM, Izutsu KT. Iatrogenic causes of salivary gland dysfunction. J Dent Res 1987;66:680-688.
30. Felder RS, Millar SB, Henry RH. Oral manifestations of drug therapy. Spec Care Dentist 1988;8:119-124.
31. Sreebny LM, Valdini A, Yu A. Xerostomia. Part II: Relationship to nonoral symptoms, drugs, and disease. Oral Surg Oral Med Oral Pathol 1989;68:419-427.
32. Persson RE, Izusu KT, Truelove EL, Rersson R. Differences in salivary rates in elderly subjects using xerostomic medications. Oral Surg Oral Med Oral Pathol 1991;72:42-46.
33. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: Old problem, new problem. Crit Rev Oral Biol Med 1991;2:103-137.
34. Rees TD, Levine RA. Systemic drugs as a risk factor for periodontal disease initiation and propagation. Compendium 1995;16:20-31.
35. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002;39:542-553.
36. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
37. Gifford RW Jr, Kirkendall W, O'Connor DT, Weidman W. Office evaluation of hypertension. A statement for health professionals by a writing group of the Council for High Blood Pressure Research, American Heart Association. Circulation 1998;79:721-731.
38. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: Their course and prognosis. Am J Med Sci 1974;268:336-345. [AU: Correct reference information?]
39. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. J Am Med Assoc 2003;289:2560-2572.
40. Siegenthaler W, Veragut M, Werning C. Blood pressure in westernized populations. In: Swales JD (ed). Textbook of Hypertension, ed 1. London: Blackwell Scientific, 1994:728.
41. Becker L, Eisenberg M, Fahrenbruch C, Cobb L. Cardiac arrest in medical and dental practices. Implications for automated external defibrillators. Arch Intern Med 2001;161:1509-1512.
42. Allen LH, Ming KI-I, Neal RG. Blood pressure and electrocardiographic response to dental treatment with use of local anesthesia. J Am Dent Assoc 1986;113:639-642.
43. Boakes AJ, Laurence DR, Lovel KW, O'Neil R, Verrill PJ. Adverse reactions to local anaesthetic/vasoconstrictor preparations. Br Dent J 1972;133:137-140.
44. Meiller TF, Overholser CD, Kutcher MJ, Bennett R. Blood pressure fluctuations in hypertensive patients during oral surgery. J Oral Maxillofac Surg 1983;41:715-718.
45. Lipp M, Dick W, Daublander M, Fuder H, Stanton-Hicks M. Exogenous and endogenous plasma levels of epinephrine during dental treatment under local anesthesia. Reg Anesth 1993;18:6-12.
46. Massalha R, Valdman S, Farkash P, Merkin L, Herishanu Y. Fatal intracerebral hemorrhage during dental treatment. Isr J Med Sci 1996;32:774-776.
47. Mito RS, Yagiela JA. Hypertensive response to levonordefrin in a patient receiving propranolol: Report of case. J Am Dent Assoc 1988;116:55-57.
48. Meyer FU. Hemodynamic changes of local anesthesia in normotensive and hypertensive subjects. Int J Clin Pharmacol Ther Toxicol 1986;24:477-481.
49. Steinman HR, Patterson SS, Newton CW, Troup P, Zipes DP. Cardiovascular changes during nonsurgical endodontics. J Endod 1982;8:497-501.
50. Singer J, Meiller TF, Rubinstein L. Blood pressure fluctuations during dental hygiene treatment. Dent Hyg (Chic) 1983;57:24-28.
51. Beck FM, Weaver JM. Blood pressure and heart rate responses to anticipated high stress dental treatment. J Dent Res 1981;60:26-29.
52. Cioffi GA, Chemow B, Glahn RP, Terezhalmy GT, Lake CR. The hemodynamic and plasma catecholamine responses to routine restorative dental care. J Am Dent Assoc 1985;111:67-70.
53. Ship II. The response of systolic and diastolic blood pressures to dental stress. Oral Surg Oral Med Oral Pathol 1960;13:499-507.
54. Gortzak RAT, Oosting J, Abraham-Inpijn L. Blood pressure response to routine restorative dental treatment with and without local anesthesia. Oral Surg Oral Med Oral Pathol 1992;73:677-681.
55. Campbell NR, McKay DW. Accurate blood pressure measurement: Why does it matter? Can Med Assoc J 1999;161:277-278.
56. Niwa H, Satoh Y, Matsuura H. Cardiovascular responses to epinephrine-containing local anesthetics for dental use: A comparison of hemodynamic responses to infiltration anesthesia and ergometer-stress testing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:171-181.
57. Bruce RA. Exercise testing for evaluation of ventricular function. N Engl J Med 1977;296:671-675.
58. Kenney WL. ACSM's Guidelines for Exercise Testing and Prescription, ed 5. Baltimore: Williams & Wilkins, 1995:93-94.
59. Campbell JH, Hulzinga PJ, Das SK, Rodriguez JP, Gobetti JP. Incidence and significance of cardiac arrhythmia in geriatric oral surgery patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:42-46.
60. Yeghiazarians Y, Braunstein JB, Askari A, Stone PH. Unstable angina pectoris. N Engl J Med 2000;342:101-104.
61. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-106.
62. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996;348:1329-1339.
63. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
64. Kirkwood TBL. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983;49:238-244.
65. Poller L. Progress in standardization in anticoagulant control. Hematol Rev 1987;1:225-241.
66. Poller L. A simple nomogram for the derivation of international normalised ratios for the standardisation of prothrombin times. Thromb Haemost 1988;60:18-20.
67. Hirsch J. Oral anticoagulants. N Engl J Med 1991;324:1865-1875.
68. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Breit E. Optimal anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-17.
69. Pineo GF, Hill RD. Adverse effects of coumarin anticoagulants. Drug Safety 1993;9:263-271.
70. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: A systematic review. Arch Intern Med 2003;163:901-908.
71. Terezhalmy GT, Lichtin AE. Antithrombotic, anticoagulant, and thrombolytic agents. Dent Clin North Am 1996;40:649-664.
72. Miller CS, Leonelli FM, Latham E. Selective interference with pacemaker activity by electrical dental devices. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:33-36.
73. Youngblood JJ, Killoy W, Love JW, Drisko C. Effectiveness of a new home plaque removal instrument in removing subgingival and interproximal plaque: A preliminary in vivo report. Compend Contin Educ Dent 1985;6:S128-S132.
74. Baab DA, Johnson RH. The effect of new electric toothbrush on supragingival plaque and gingivitis. J Periodontol 1989;60:336-341.
75. Killoy WJ, Love JW, Love J, Fedi PF Jr, Tira DE. The effectiveness of a counter-rotary action powered toothbrush and conventional toothbrush on plaque removal and gingival bleeding. A short term study. J Periodontol 1989;60:473-477.
76. Wilcoxon DB, Ackerman RJ Jr, Killoy WS, Love JW, Sakumura JS, Tira DE. The effectiveness of a counterrotational-action power toothbrush on plaque control in orthodontic patients. Am J Orthod Dentofac Orthop 1991;99:7-14.
77. IADR abstracts. Chicago. Illinois, March 10-14, 1993. J Dent Res 1993;72(special issue):333.
78. Wilson S, Levine D, Dequincey G, Killoy WJ. Effects of two toothbrushes on plaque, gingivitis, gingival abrasion, and recession: A 1-year longitudinal study. Compend Suppl 1993;16:S569-S579.
79. Yukna RA, Shaklee RL. Interproximal vs midradicular effects of a counter-rotational powered brush during supportive periodontal therapy. Compend Suppl 1993;16:S580-S586.
80. Love JW, Drisko CL, Killoy WJ, Tira DE, Love JD. Clinical assessment of the INTERPLAK toothbrush vs a conventional brush plus floss. Compend Suppl 1993;16:S587-S598.
81. Blahut P. A clinical trial of the INTERPLAK powered toothbrush in a geriatric population. Compend Suppl 1993;16:S606-S610.
82. Terezhalmy GT, Gagliardi VB, Rybicki LA, Kauffman MJ. Clinical evaluation of the efficacy and safety of the UltraSonex ultrasonic toothbrush: A 30-day study. Compendium 1994;15:866-874.
83. Terezhalmy GT, Iffland H, Jelepis C, Waskowski J. Clinical evaluation of the effect of an ultrasonic toothbrush on plaque, gingivitis, and gingival bleeding: A six-month study. J Prosthet Dent 1995;73:97-103.
84. Whitmyer CC, Terezhalmy GT, Miller DL, Hujer ME. Clinical evaluation of the efficacy and safety of an ultrasonic toothbrush system in an elderly patient population. Geriatr Nurs 1998;19:29-33.
85. Shinada K, Hashizume LN, Teraoka K, Kurosaki N. Effect of ultrasonic toothbrush on Streptococcus mutans. Jpn J Conserv Dent 1999;42:410-417.
86. Keltjens H, Schaeken T, van der Hoeven H. Preventive aspects of root caries. Int Dent J 1993;43:143-148.
87. Ten Cate JM, Parsh PD. Procedures for establishing efficacy of antibacterial agents for chemotherapeutic caries prevention. J Dent Res 1994;73:695-703.
88. Dunn CJ, Goa KL. Tranexamic acid: A review of its use in surgery and other indications. Drugs 1999;57:1005-1032.